Systems Oncology
Business Services · Arizona, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7201 E Henkel Way Ste 205, Scottsdale, A...Phone Number
(480) 422-2320Website
www.systemsoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Systems Oncology
Systems Oncology specializes in translating big data into innovative cancer therapies through advanced cognitive computing technologies. Their unique approach involves aggregating and analyzing diverse biomedical datasets to identify therapeutic vulnerabilities in cancer, which they then exploit in collaboration with leading universities and pharmaceutical companies. The company aims to accelerate cancer drug development by investing in promising experimental agents and demonstrating their therapeutic potential. Their intended clients include pharmaceutical companies seeking to partner in the development of breakthrough cancer therapies.Explore more
Systems Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Systems Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Systems Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Systems Oncology is spiking on competitors!
Earning: See what the market has to say on Systems Oncology recently announced quarterly report
Product Launch: Get notified when Systems Oncology launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Systems Oncology has new funding data
Check if Systems Oncology has recently received funding, and reach out quickly before it becomes old news!
Click to see if Systems Oncology had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Systems Oncology
Recommended Actions
Reach out to Masked Content who joined Systems Oncology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Systems Oncology
Compare insights from companies similar to Systems Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$6.5M
11-50
Public
$340.5M
2015
KB
Kristi BalacyHead Senior Director, Clinical Development Operations & of Clinical Operations
Company Profile Activity
Activity Insights
Systems Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Systems Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Systems Oncology.
Systems Oncology Tech Stack
A closer look at the technologies used by Systems Oncology
See more technologies
Systems Oncology News & Media
INVEST Pitch Perfect winner spotlight: Systems Oncology's AI tech yields trove of cancer drugs
Systems Oncology has used its its artificial intelligence to discover small molecules in development under partnerships with large pharma companies. The R&D of the company, the biopharma startup winner in the Pitch Perfect contest at the recent MedCity News INVEST Conference, includes a new type of RNA drug.Systems Oncology to Participate in Fireside Chat at RBC Capital Markets Global Healthcare Conference
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Systems Oncology, a biotechnology company, today announced that Dr. Spyro Mousses, CEO and Co-Founder of Systems Oncology, will participate in a fireside chat at the 2021 RBC Capital Markets Global Healthcare Conference on Thursday, May 20th at 12:40pm EST. Management will host one-on-one investor meetings at the conference. To request a meeting with management, please contact your registered RBC representative or Andrew Matricaria, CFO of Systems Oncology, aSystems Oncology to Present at BMO BioPharma Spotlight Series
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Systems Oncology, an AI-based pharmatech company, today announced that Dr. Spyro Mousses, CEO and Co-Founder of Systems Oncology, will present at the BMO BioPharma Spotlight Series: Technology-Enabled Drug Discovery on Friday, April 16th at 11.15 AM EST. Systems Oncology will review its unique strategy for leveraging AI-based multi-target discovery, and unveil its transformative RNAi therapeutic platform for creating innovative RNA drugs that can overcome theSystems Oncology, an AI-based Cancer Therapy Discovery and Development Company, Is Honored With a 2020 AZBio Fast Lane Award
CHANDLER, Ariz.--(BUSINESS WIRE)-- #AZBW--Systems Oncology is using AI to Innovate Drug Discovery & Development and is being honored with a 2020 AZBio Fast Lane Award for their achievements.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Systems Oncology
Sign Up For FreeTo access detailed company insights
Systems Oncology specializes in translating big data into innovative cancer therapies through advanced cognitive computing technologies. Their unique approach involves aggregating and analyzing diverse biomedical datasets to identify therapeutic vulnerabilities in cancer, which they then exploit in collaboration with leading universities and pharma... Read More
